ExploreWatchlistsPricing
  1. JP-listed companies
  2. BML, INC.
  3. Financials
  4. Return on Assets

BML, INC. (4694)

Market cap
¥163.7B
P/E ratio
25.2x
BML provides clinical laboratory testing services to hospitals and clinics across Japan, along with food safety testing and clinical trial support through its network of specialized subsidiaries.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Mar 31, 20253.7+1.63%
Mar 31, 20243.7-60.34%
Mar 31, 20239.3-57.39%
Mar 31, 202221.8+94.81%
Mar 31, 202111.2+90.78%
Mar 31, 20205.9-7.57%
Mar 31, 20196.3+5.32%
Mar 31, 20186-4.29%
Mar 31, 20176.3+3.80%
Mar 31, 20166.1

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat